Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4Boehringer Ingelheim[edit] Footnotes^ Yamatake Y, Sasagawa S, Yanaura S, Okamiya Y (1977). "[Antiallergic indications for atrovent effect of indications for atrovent bromide (Sch 1000) in dogs.

number 60205-81-4ATC code R01AX03 R03BB01PubChem indications for atrovent APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability ?Protein binding 0 to 9% in vitroMetabolism HepaticHalf life 2 hoursExcretion ?Therapeutic considerationsPregnancy cat. B(US)Legal status POM(UK)Routes InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for the treatment of obstructive indications for atrovent indications for atrovent It acts by blocking indications for atrovent receptors indications for atrovent the lung, inhibiting bronchoconstriction and mucus secretion. It is a quaternary amine and therefore does not diffuse into the blood, which prevents systemic side effects. Ipratropium is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the treatment indications for atrovent obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting indications for atrovent and mucus.

POM(UK)Routes InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic.